Sydney, Australia, Nov. 25, 2016 -- Heron Resources Limited (Heron) is pleased to announce that the exposure period for the initial public offer Prospectus for Ardea Resources Limited (Ardea, ASX:ARL) has ended and applications for Ardea Shares can now be accepted, both through the Public Offer and through the Priority Offer for Heron shareholders.
The Prospectus for the Priority and Public Offers with appropriate Application Forms will be mailed to Heron shareholders with a registered address inside Australia on 28 November 2016.
Should Heron shareholders wish to apply under their Priority Offer before mailed receipt of the Prospectus, the appropriate documents can be obtained by emailing or telephoning the share registry, Security Transfer Australia:
Telephone 08 9315 2333
Email [email protected]
Any request for a Prospectus or other enquiries can also be directed to the Security Transfer at the preceding contacts, or alternatively telephone Ardea direct on 08 6500 9200.
It should be noted that Heron shareholders will separately receive their In-Specie distribution shares from the 6 October 2016 Record Date once Ardea lists on ASX, expected to be January 2017.
Public applications can be downloaded from www.ardearesources.com.au or from www.securitytransfer.com.au, with payment by BPAY® available. Anyone wishing to acquire Ardea Shares will need to complete the application form that is in the back of the Prospectus or follow the instructions for an electronic application.
Ardea Resources Limited Tel: +61 8 6500 9200


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



